114 related articles for article (PubMed ID: 1696908)
1. [The anti-allergic activity and mechanism of action of gamma-carboline derivatives].
Kiseleva EE; Zakharevskiĭ AS; Nikiforova IN
Farmakol Toksikol; 1990; 53(3):22-4. PubMed ID: 1696908
[TBL] [Abstract][Full Text] [Related]
2. [Anti-allergic properties of dimebon, fencarol and ketotifen in sensitization by common ragweed pollen].
Galenko-Iaroshevskiĭ PA; Shadurskiĭ KS; Il'iuchenok TI; Pasechnikov FG; Khanferian RA
Farmakol Toksikol; 1984; 47(3):75-8. PubMed ID: 6145622
[TBL] [Abstract][Full Text] [Related]
3. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
4. Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agent.
Rosenthale ME; Begany AJ; Dervinis A; Sellstedt J; Guinosso C; Gluckman MI
J Pharmacol Exp Ther; 1976 Jun; 197(3):725-33. PubMed ID: 58988
[TBL] [Abstract][Full Text] [Related]
5. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
[TBL] [Abstract][Full Text] [Related]
6. The anti-anaphylactic effect of the gall of Rhus javanica is mediated through inhibition of histamine release and inflammatory cytokine secretion.
Kim SH; Park HH; Lee S; Jun CD; Choi BJ; Kim SY; Kim SH; Kim DK; Park JS; Chae BS; Shin TY
Int Immunopharmacol; 2005 Dec; 5(13-14):1820-9. PubMed ID: 16275618
[TBL] [Abstract][Full Text] [Related]
7. [Anti-anaphylactic activity of l-methyl-3-isobutylxanthine].
Gushchin IS; Sviridov VV
Patol Fiziol Eksp Ter; 1977; (4):32-6. PubMed ID: 73161
[No Abstract] [Full Text] [Related]
8. [Experimental study on the action mechanism of a new bronchodilator agent, BB-1502].
Kamei H; Obi Y; Kawano K; Hirano M; Murata S; Imanishi H
Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):335-42. PubMed ID: 6200410
[TBL] [Abstract][Full Text] [Related]
9. [Anti-allergic properties of a novel ethyl 3-(8-fluoro-2-methyl-2,3,4,5-tetrahydropyrido[4,3-b]indol-5-yl)propionate dihydrochloride].
Ivashchenko AV; Kadieva MG; Kravchenko DV; Lavrovskiĭ IaV; Mit'kin OD; Salimov RM; Fedotov IuA
Eksp Klin Farmakol; 2010 Mar; 73(3):28-30. PubMed ID: 20408427
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel 5,8-disubstituted-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b] indoles as 5-HT(6) and H(1) receptors antagonists.
Ivachtchenko AV; Frolov EB; Mitkin OD; Kysil VM; Khvat AV; Tkachenko SE
Arch Pharm (Weinheim); 2009 Dec; 342(12):740-7. PubMed ID: 19921682
[TBL] [Abstract][Full Text] [Related]
11. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
[TBL] [Abstract][Full Text] [Related]
12. 4-(p-Chlorophenylthio)butanol (W-2719), a new non-antihistaminic drug for immediate hypersensitivity allergies.
Fukui GM; Ludwig BJ; Sofia RD; Reisner DB; Berger FM
Arzneimittelforschung; 1979; 29(6):912-7. PubMed ID: 90512
[TBL] [Abstract][Full Text] [Related]
13. Effect of a major metabolite of the antiallergic drug repirinast on phosphodiesterase and adenylate cyclase activities.
Yamada N; Arai Y; Funayama K; Kadowaki S; Takahashi K; Umezu K
Arzneimittelforschung; 1995 Jan; 45(1):33-5. PubMed ID: 7534459
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.
Ivachtchenko AV; Frolov EB; Mitkin OD; Kysil VM; Khvat AV; Okun IM; Tkachenko SE
Bioorg Med Chem Lett; 2009 Jun; 19(12):3183-7. PubMed ID: 19443217
[TBL] [Abstract][Full Text] [Related]
15. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
[TBL] [Abstract][Full Text] [Related]
16. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 2nd communication: inhibitory effects on histamine release from rat mast cells and lung fragments.
Yanagihara Y; Abe T; Kuroda T; Shida T
Arzneimittelforschung; 1988 Jan; 38(1):75-9. PubMed ID: 2452639
[TBL] [Abstract][Full Text] [Related]
17. [The search for new antiallergy compounds among a number of coumarin derivatives and the study of their mechanisms of action].
Saraf AS; Simonian AV; Oganesian ET
Eksp Klin Farmakol; 1993; 56(2):47-50. PubMed ID: 7688624
[TBL] [Abstract][Full Text] [Related]
18. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
Yamamura H; Kohno S; Ohata K
Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of MY-1250, an active metabolite of Repirinast, in inhibiting histamine release from rat mast cells.
Takei M; Endo K; Takahashi K
Br J Pharmacol; 1992 Mar; 105(3):587-90. PubMed ID: 1378339
[TBL] [Abstract][Full Text] [Related]
20. [Substituted 2,3,4,5-tetrahydro-1H-gamma-carbolines: new antagonists of histamine H1 receptors].
Ivashchenko AV; Mit'kin OD; Okun' IM; Salimov RM; Fedotov IuA
Eksp Klin Farmakol; 2010 Nov; 73(11):25-9. PubMed ID: 21254595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
